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Viral RNA export 
Thomas J Hope 
Viruses can express intron-containing and intronless mRNAs, 
which are exported by alternative pathways. The study of the 
nuclear export of these unconventional mRNAs can provide 
key insights into the normal process of nuclear export and the 
alternative pathways provide an attractive target for the 
development of specific antiviral therapies. 
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Introduction 
Recent studies of viral gene expression have revealed that 
RNA export is a highly regulated process. Unlike most 
cellular mRNAs, which contain introns that are removed 
before an mRNA is exported to the nucleus, viruses often 
express unconventional mRNAs; these are either intron- 
less or retain potential introns, but they are still efficiently 
exported to the cytoplasm. Viruses use endogenous cellu- 
lar pathways to export their unconventional mRNAs, so 
understanding viral mRNA export can provide important 
insights into the process of nuclear export in normal cell 
function. Because many viruses depend on alternative 
pathways for mRNA export; these pathways provide an 
attractive target for the development of specific antiviral 
therapies. If the alternative pathways can be understood, 
all the human viruses which replicate in the nucleus - 
viruses ranging from the human immunodeficiency virus 
(HIV) and the human hepatitis B virus (HBV) to herpes 
viruses and influenza - may be vulnerable to therapeutic 
strategies which target viral RNA export. 
The classical system for studying mRNA export is an 
assay in which radiolabeled RNAs are injected into the 
nuclei of Xenopus oocytes [ 11. This technique allows direct 
monitoring of the movement of RNA from the nucleus to 
the cytoplasm. During the experiment, the microinjected 
oocytes are incubated and then separated into nuclear and 
cytoplasmic fractions. The RNA in each compartment is 
then analyzed by gel electrophoresis. Such microinjection 
analysis has revealed that RNA export is a carrier-medi- 
ated, energy-dependent, saturable process [l-3]. Compe- 
tition studies with mRNAs, rRNAs, tRNAs, and the 
snRNAs suggest that they use four separate pathways 
which are dependent on distinct cellular factors [Z]. 
Cellular mRNA export 
Most of the mRNAs in higher eukaryotes contain introns. 
Because of the potential deleterious effects of translating 
intron-containing messages, such as premature termination 
or the generation of inappropriate polypeptides, all introns 
must be removed before an RNA is allowed to be exported 
from the nucleus. For example, it has been shown in the 
case of yeast that the assembly of splicing complexes 
without completion of the splicing reaction, can inhibit the 
export of RNA [4] - so splicing must be completed 
before the active process of retention in the nucleus is 
halted. In addition, the process of splicing appears to have 
a positive effect on RNA export. The first hints of a posi- 
tive role for splicing, and therefore the involvement of an 
intron, in RNA export came from studies of Simian virus 
40 (SV40) [S]. The analysis of a mutant derivative of SV40 
that lacked an intron in the late region of the viral genome 
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demonstrated that although the transcription of SV40 late 
transcripts appeared to be normal, these transcripts failed 
to accumulate in the cytoplasm. The involvement of a 
functional intron in export has also been shown for 
B-globin [6,7], the ribosomal protein L32 [8], immunoglob- 
ulin F [9], and several other mRNAs. In addition, in the 
expression of cellular cDNAs from expression vectors used 
in making transgenic mice and in the generation of stable 
expression in cell lines, the presence of an intron greatly 
increases gene expression, presumably by increasing the 
efficiency of the export of the cDNAs [7]. 
Viral export of intron-containing mRNAs 
The requirement that intronic sequences must be deleted 
before an mRNA can be exported poses a serious problem 
for complex retroviruses such as HIV, which encodes nine 
proteins within a relatively small, 10,000 base pair genome. 
Three different classes of mRNAs are generated by the 
virus - unspliced, partially spliced, and completely 
spliced mRNAs. All viral mRNAs encode viral proteins. 
The unspliced RNA also functions as the genomic RNA, 
which must be present in the cytoplasm in order to be 
incorporated into virions which are assembling at the 
plasma membrane. Therefore, HIV must efficiently export 
incompletely spliced and unspliced RNA from the 
nucleus, even though normal nuclear checkpoints are 
designed to block the export of such transcripts. To bypass 
this checkpoint, HIV expresses a protein called Rev, 
which is responsible for the efficient export of unspliced 
and incompletely spliced viral mRNAs [lo]. All complex 
retroviruses express proteins functionally related to Rev. 
In lentiviruses these proteins are known as Rev, whereas 
in the complex oncoviruses they are known as Rex. For 
the sake of simplicity, I refer to all these regulatory factors 
as Rev-like proteins. 
Export by complex retroviruses 
Rev-like proteins interact with a folded RNA structure 
that is contained in the viral RNA, thus facilitating the 
specific export of viral RNA. By expressing a Rev-like 
protein, complex retroviruses can specifically regulate the 
export and subsequent expression of incompletely spliced 
and unspliced RNA. This control of viral gene expression 
is likely to regulate the timing of protein production, 
thereby regulating levels of virion production. 
Figure 1 shows the regulation of RNA export by complex 
retroviruses. The virus expresses early genes, which are 
encoded by conventionally spliced messages, using the 
normal pathway for mRNA export from the nucleus 
(Step 1). One of the early genes encodes a Rev-like post- 
transcriptional transactivator, which is imported into the 
nucleus through interactions with its nuclear localization 
signal (Step 2) [ll]. When the Rev-like protein accumu- 
lates to the levels required, nuclear export of incom- 
pletely spliced and unspliced RNA is initiated (Step 3) 
[l&13]. This leads to the expression of viral late genes 
and subsequent virion assembly. 
Export by simple retroviruses 
The simple retroviruses contain a single potential intron 
and therefore encounter the same dilemma faced by the 
complex retroviruses: they must export unspliced RNA 
which retains an intron [14]. But, unlike the complex 
retroviruses, the simple retroviruses do not express a Rev- 
like protein. Instead, they contain a binding site for cellu- 
lar factors which mediate the nuclear export of unspliced 
RNAs. Such binding sites for cellular factors, required for 
the cytoplasmic localization of unspliced RNAs, have 
been found in the type D retroviruses [15] and avian 
leukosis viruses (ALVs) [16]. A critical consequence of 
using cellular factors is that nuclear export is constitutive: 
in other words, because the factors mediating export are 
always present, there is no differential expression of early 
and late genes. 
The constitutive transport element (CTE) found in 
type D retroviruses is the best characterized of the ele- 
ments that bind cellular factors in order to mediate export 
of unspliced RNA. The secondary structure of this CTE 
has recently been determined by mutational and biochem- 
ical analysis [17,18]. It consists of an extended, imperfect 
stem-loop with two large non-base-paired regions, or 
‘bubbles’. Remarkably, the two bubble regions are com- 
posed of identical sequences which are rotated by 180” rel- 
ative to each other [17]. The structure of the type D 
retrovirus CTE and the related structure of the two bubble 
regions is shown in Figure 2. Point mutations in either 
bubble region have been shown to abrogate CTE func- 
tion. These regions of primary sequence have therefore 
been proposed to act as binding sites for the cellular 
factors that mediate RNA export. A related RNA element, 
which contains two bubble regions identical to those found 
in the CTEs of type D retroviruses, has been identified in 
the intracisternal-A particle retroelement [19]. 
It has recently been proposed that the nuclear protein RNA 
helicase A is the cellular factor that mediates the function of 
the CTE of type D retroviruses (201. RNA helicase A was 
initially identified in nuclear extracts as a cellular protein 
that bound to CTE RNA but not to a mutant form of the 
CTE RNA that is non-functional in aivo. In addition, RNA 
helicase A became relocated to the cytoplasm when RNAs 
containing wild-type CTE sequences were expressed. This 
observation is consistent with what one might expect for a 
cellular equivalent of the viral Rev-like proteins. RNA heli- 
cases are also known to be involved in the cytoplasmic 
localization of maternal RNAs within Drosophila 
mdanogaster oocytes [Zl]. Although the observations out- 
lined here are consistent with the involvement of RNA 
helicase A in the export function of the type D retrovirus 
CTE, the exact role of RNA helicase A remains unknown. 
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Figure 1 
Viral RNA export in complex retroviruses. The 
expression of early and late genes by complex 
retroviruses is illustrated (HIV is used in this 
example). After the transcription of viral RNA 
begins, only completely spliced mRNAs are 
exported to the cytoplasm and translated 
(Step 1). One of the early gene products, Rev, 
returns to the nucleus (Step 2) where it 
interacts with an RNA structure located within 
the second intron of viral transcripts. 
Interaction of Rev with the Rev-response 
element (RRE) leads to the export of 
unconventional mRNAs (Step 3) and the 
expression of the viral late genes. or incompletely 
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Viral export of intronless mRNAs 
The presence of specific RNA export elements in retro- 
viruses indicates that facilitated export is required for the 
export of intron-containing RNAs. Functionally related 
RNA export elements have also been identified in the 
intronless RNAs of HBV and in the intronless thymidine 
kinase (TK) gene of the human herpes simplex virus 
(HSV). Furthermore, evidence suggests that the intronless 
late genes of human papillomavirus (HPV) contain cell- 
type specific RNA export elements. The expression of 
HPV late genes is limited to terminally differentiated ker- 
atinocytes, but late-gene expression can be induced in 
fibroblasts when Rev is expressed, and the RRE is con- 
tained in intronless late-gene mRNAs [‘&.?I. The presence 
of these elements in intronless viral RNAs suggests that 
the facilitation of RNA export may be required for the eff- 
cient cytoplasmic localization and subsequent translation 
of intronless mRNAs. As for the RNA export elements in 
simple retroviruses, the expression of viral proteins is not 
required for the function of the elements found in HBV, 
HSV, and HPV. Therefore, the function of these elements 
is believed to be mediated by cellular proteins. 
Studies of the enhancer I region of HBV by Vannice and 
Levinson [23] indicated that some of the enhancement of 
gene expression mediated by this region was dependent 
on its orientation. More recent studies of this region have 
identified a posttranscriptional regulatory element (PRE) 
that is required for the cytoplasmic localization and 
expression of HBV mRNAs encoding the HBV Surface 
protein. The PRE may also be involved in the expression 
of all the intronless transcripts of HBV [24,25]. 
The folded structure of the RNA export element in HBV 
(HBV PRE) has not been determined, although initial 
mapping studies indicate that it is composed of two dis- 
tinct regions, or sub-elements, which are required for eff- 
cient function [26]. The sub-elements appear to be 
functionally equivalent, because the duplication of either 
element activates RNA export to levels similar to those 
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The structure of the type D retrovirus constitutive transport element 
(CTE). The secondary RNA structure of the CTE is shown (derived 
from the structure determined by Ernst et al. [17]) The structures of 
the two conserved loop regions are shown on the right. The repeats 
are indicated by 1 and 2 within the light blue shading. The colors 
denote different nucleotides. 
found for the native HBV PRE. Cellular factors which 
interact with the HBV PRE have recently been identified 
using in vitro RNA-binding assays [27], but their involve- 
ment in RNA export remains to be demonstrated. Studies 
by Huang and Yen [28] have shown that an intron of the 
B-globin gene can replace the HBV PRE in facilitating the 
export of the HBV Surface protein mRNAs. This is con- 
sistent with the HBV PRE providing a role analogous to 
the export activity associated with RNA splicing. Further 
evidence for the export function of the HBV PRE comes 
from the use of the 3’ end of HBV in vectors used for 
cDNA expression in transgenic mice [29]. Although it was 
not realized at the time, the presence of the HBV PRE 
was facilitating the export of intronless cDNAs generated 
by this type of vector. 
The intronless TK gene in HSV has also been shown to 
contain an element which facilitates RNA export [7,30]. 
To understand the cytoplasmic localization of the intron- 
less TK mRNA, chimeric RNAs were generated contain- 
ing an intron from the B-globin gene fused to the TK 
gene. The chimeric RNA was found to be efficiently 
exported to the cytoplasm while retaining the B-globin 
intron [30]. Detailed analysis of the export activity of the 
TK gene identified an RNA element, known as the pre- 
mRNA processing element (PPE) which could mediate 
the efficient nuclear export of a B-globin cDNA [31]. The 
PPE has been shown to interact with the cellular factor 
heteronuclear RNA-binding protein L (hnRNP L) [31], 
and mutational analysis of the PPE has shown that this 
interaction correlates with PPE’s mediation of nuclear 
export. The structure of the PPE element has not yet 
been determined. 
Viral proteins which mediate unconventional 
mRNA export 
Studies of the Rev-like proteins of complex retroviruses 
provides most of the knowledge on the structure and func- 
tion of the proteins which mediate the export of viral 
RNAs. The most studied of these proteins is HIV Rev. At 
least two essential functions have been assigned to Rev 
and the Rev-like transactivators: a specific RNA-binding 
activity which directs specific interactions with viral 
mRNAs; and the cytoplasmic localization of unconven- 
tional viral mRNAs by an effector domain [11,32]. Rev- 
like proteins therefore act as adapters that impart a 
specificity for viral RNA with the cellular export pathway. 
For many years the exact mechanism of action of Rev was 
controversial: in one model, Rev inhibited splicing, 
leading to cytoplasmic localization; and in the other 
model, Rev directly facilitated the export of intron-con- 
taining viral mRNAs [10,33]. Recently, HIV Rev has been 
shown to directly facilitate RNA export [34-361. 
The first direct evidence that Rev was facilitating RNA 
export came from studies of Rev function in Xenopus 
oocytes [34]. When Rev was injected into oocytes with an 
RNA substrate containing the second intron of HIV 
(which contains the RRE), unspliced substrate RNA 
became cytoplasmically localized in a Rev-dependent 
manner. Surprisingly, the excised product generated by 
the splicing of the injected RNA substrate, also became 
cytoplasmically localized. It was difficult to envision a 
model in which the inhibition of splicing by Rev would 
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lead to the cytoplasmic localization of the excised product 
of the splicing reaction. But the cytoplasmic localization of 
the excised product was consistent with a model in which 
Rev would directly export any RNA containing an RRE. 
The proof that the mechanism of Rev function was direct 
nuclear export came when it was determined that the 
effector domain of HIV Rev was, in fact, a nuclear export 
signal (NES) [35,36]. The ability of the effector domain 
of HIV to act as an NES was shown directly using 
microinjection analysis. It was shown that when pepcides 
corresponding to the effector domain of HIV-l Rev were 
cross-linked to bovine serum albumin (BSA), they could 
facilitate the cytoplasrnic localization of BSA-peptide 
(BSA-NES) conjugates that had been microinjected into 
the nucleus of Xenopzls oocytes and mammalian fibro- 
blasts. Conjugates containing a peptide corresponding to 
a non-functional effector-domain mutant of Rev were not 
exported from the nucleus. The export of the BSA-NES 
conjugates was energy-dependent (export was completely 
blocked at 4°C); the NES-mediated export pathway was 
saturable; and the injection of excess unlabeled BSA- 
NES conjugates could block the export of labeled conju- 
gates, indicating that export of this class of NES is medi- 
ated by a factor present in limiting amounts in the 
nucleus. Wheat germ agglutinin (WGA) can inhibit the 
import function of the nuclear pore by interacting with 
complex sugars on proteins within the nuclear pore [37]. 
WGA can also inhibit the export of BSA-NES conjugates, 
suggesting that the export of these signals is mediated by 
the nuclear pore [38]. 
Because the Rev-like proteins contain both a nuclear 
localization signal (NLS) and an NES they move continu- 
ously between the cytoplasm and the nucleus [39]; for this 
reason they are known as shuttle proteins. By shuttling, it 
is possible for a single Rev protein to mediate the export 
of many viral RNAs. Like that of several of the hnRNPs, 
the shuttling of the Rev-like proteins is dependent on 
active transcription [40]; if cellular transcription is inhib- 
ited by a drug such as actinomycin D or 5,6-dichlorobenz- 
imidazole riboside (DRB), shuttle proteins accumulate in 
the cytoplasm. 
Competition studies with BSA-NES conjugates in 
Xenopzls oocytes revealed that Rev-mediated export relies 
on the export pathway used by 5S ribosomal RNA and 
small nuclear RNAs, rather than that typically used by 
mRNAs [35]. These observations indicate that the previ- 
ously observed Rev-dependent inhibition of splicing is 
indirectly caused by the export of unspliced RNA [41]. 
Export thus removes a potential substrate (unspliced 
RNA) for the splicing reaction. It is known that the tran- 
scription factor TFIIIA activates the expression of the 5S 
RNA; TFIIIA can also interact with 5S RNA to form a 
complex, TFIIIA-5S RNA, which is then exported to the 
cytoplasm in Xenopus oocytes. Export of this complex is 
mediated by an NES in TFIIIA which is structurally and 
functionally related to the NES present in HIV Rev [42]. 
It is possible functionally to replace the NES in HIV Rev 
with the TFIIIA NES. Furthermore, the Rev NES can 
block export mediated by the TFIIIA NES by competing 
for common factors in Xenopus oocyte injection assays. In 
addition, alignment of the Rev and TFIIIA NES 
sequences reveals that the positioning of several amino 
acids is conserved. The related nature of the NESS in 
TFIIIA and Rev supports a model in which Rev directs 
the export of intron-containing HIV RNAs along a 
pathway not typically used by cellular mRNAs. 
Nuclear export signals in cellular proteins 
Structurally and functionally equivalent NESS have been 
identified in cellular proteins involved in RNA metabo- 
lism. The fragile X mental retardation protein type 1 
(FxMRPl) contains an NES [43,44] which can be used to 
complement the function of an NES mutant of Rev [44]. It 
has been shown that the NES of FxMRPl is located in the 
region encoded by exon 14, and is essential for the proper 
localization of FxMRPl. When the NES of FxMRPl is 
mutated, the normally cytoplasmically localized protein 
becomes completely nuclear. A recessive-negative form of 
FxMRPl results from the exclusion of exon 14 and, unlike 
wild-type FxMRPl which is localized in the cytoplasm, 
this form is localized in the nucleus. It is believed that 
FxMRPl first moves to the nucleus where it interacts with 
an unidentified cellular RNA, the FxMRPl-RNA com- 
plex is then exported to the cytoplasm where the complex 
is involved in cellular translation [44]. 
An NES has also been identified in the Glel protein of 
&&zaromyces cet-tmisiae [45]. Mutants of the GLEl are 
defective in the nuclear export of polyadenylated mRNAs. 
The Glel NES is required for the Glel function, and the 
related structures of the yeast-derived and higher eukary- 
otic NESS indicate that factors involved in mediating 
nuclear export are conserved in all eukaryotes 
The same nuclear export pathway is also used by cellular 
proteins that are not involved in RNA metabolism. The 
inhibitor of the CAMP-dependent protein kinase (PKI) 
has been shown to contain an NES which is structurally 
and functionally related to those found in the Rev-like 
proteins [36]. The NES of PKI can restore the function of 
an NES mutant of HIV-l Rev [46]. In addition, the PKI 
NES can block the export of the Rev NES when present 
in excess in microinjection analysis [36]. Related NESS 
have also been identified in Ran-binding protein 1 
(RanBPl) [47], MAP kinase kinase (MEKK) [48], and the 
inhibitor of nuclear factor kappa B alpha (IKB~) [49]. 
Finding NESS in proteins that have no involvement in 
RNA metabolism indicates that this pathway of RNA 
export is used by a variety of cellular proteins. 
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Figure 3 
Typical nuclear export signal 
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IxBci IQQQLGQLTLE 
HIV-1 LPPLERLTLD 
Visna MVGl"JEMLTLE 
HIV-2 IQHLQGLTIQ 
TFIIIA LVLDKLTIQ 
FxMRPl LRLERLQID 
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Alignment of the sequences of nuclear export 
signals. Both the typical and atypical NESS 
are shown. The core tetramer regions are 
shown in red. Leucines and chemically related 
amino acids which are involved in NES 
function are underlined. Two methionines, 
which are potentially involved in the function 
of the feline immunodeficiency virus (FIV) Rev 
NES, are underlined with a dotted line. 
Atypical nuclear export signal 
FIV KKMMTDLEDRFRKLFGSPSKDEYT - - 
EIAV P&ESDQWCRV&RQSLPEEKIP 
Structure of nuclear export signals 
Mutational analysis of several different NESS has impli- 
cated leucines, or chemically related amino acids, as 
being essential for export function (for the sake of sim- 
plicity, these conserved, leucine-related amino acids will 
be referred to here as leucines). The sequences of a 
number of known NESS are shown in Figure 3. Typical 
NESS contain a conserved motif (LXLY) consisting of 
two leucines spaced by a single amino acid [32], known 
as the core tetramer. The Y position is usually occupied 
by a charged amino acid, whereas the X position is highly 
variable. Two other leucines that are required for export 
function are found within an eight amino acid sequence 
located upstream of the core tetramer. The exact posi- 
tion of the two upstream leucines is highly variable (as 
seen in Figure 3; leucines that are important in NES 
function are underlined). 
The functional flexibility of the upstream leucines was 
demonstrated directly when it was shown that the posi- 
tions of the upstream leucines could be shifted within the 
NES of human lymphotrophic virus 1 (HTLV-1) Rex 
without revoking function [38,50]. These studies also 
showed that it is possible to replace the leucines typically 
found in NESS with any large, hydrophobic amino acid 
including isoleucine, valine, methionine, cysteine, phenyl- 
alanine, and tryptophan. The NESS found in the Rev pro- 
teins of equine infectious anemia virus (EIAV) and feline 
immunodeficiency virus (FIV) have atypical sequences 
[51,52], as shown in Figure 3. Although the function of 
these NESS is mediated by hydrophobic amino acids, as 
for the typical NESS, the spacing of important amino acids 
is distinct. Because the injection of excess NESS of either 
typical and atypical sequence will block the function of 
NESS of the other type [53], the two classes of NESS are 
believed to interact with common factors or to use the 
same export pathway. 
Cellular factors which interact with NESS have now been 
identified. The nucleoporin known as Rab or Rip has 
been shown to interact with the NESS of HIV Rev, visna- 
maedi virus Rev, EIAV Rev, HTLV-1 Rex, Glel, and 
IKBCX [54-561. In fact, the NESS have been shown to inter- 
act with domains found in many nucleoporins, which 
contain many copies of the phenylalanine-glycine repeat 
(FG repeat) [49,.57]. The cellular protein eIF5A has also 
been shown to interact specifically with the NES of HIV-l 
Rev [%I. Dominant-negative forms of eIF5A have been 
generated which can block HIV-l Rev function [59]. In 
addition, eIF5A has been shown to be specifically 
exported from the nucleus after injection into the nuclei 
of fibroblasts [59]. This observation is consistent with the 
possibility of a direct role for eIF5A in HIV-l Rev func- 
tion. The exact involvement of eIFSA and RAB/RIP in 
mediating the export of proteins containing NESS remains 
to be determined. 
RNA binding by HIV-1 Rev 
It is clear that all the Rev-like proteins contain structurally 
related and functionally equivalent NESS, and it appears 
that they can interact with RNA using a variety of mecha- 
nisms. This is demonstrated best by the observation that 
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it is possible to target HIV Rev and HTLV Rex to interact 
with RNA using the RNA-binding specificity of the bacte- 
riophage MS2 coat protein [60,61]. Fusion of the coat 
protein to Rev or Rex generates export proteins which can 
direct the cytoplasmic localization of intron-containing 
RNA when multiple copies of the binding site for the 
MS2 coat protein are present. This result shows that all 
that is required for the export of RNA is the tethering of 
proteins which contain NESS. 
The interactions between Rev and the RRE have been 
extensively characterized and the structure of the RNA- 
binding site of REV and a peptide encompassing the 
RNA-binding domain has been solved by nuclear mag- 
netic resonance (NMR) analysis. The RNA-binding 
domain of Rev is an arginine-rich motif (ARM). Mutations 
within this region have been shown to block Rev function 
in viva and RNA-binding activity in vitro [32,62]. Peptides 
encompassing the region of amino acids 34-50 of Rev have 
been shown to interact specifically with the RRE [63]. 
The sequence of the Rev ARM is shown in Figure 4a. 
The ARM also encompasses the nuclear and nucleolar 
localization signals of Rev [64,65]. Circular dichroism (CD) 
analysis of peptides encompassing the Rev ARM indicates 
that this region can form an a-helical structure [66]. 
Although the RRE is a 250 base pair, highly structured 
RNA, the sequences required for Rev binding are located 
within a small stem-loop structure [lo]. This structure, 
known as the high-affinity Rev-binding site, consists of a 
small bubble located within a stem-loop [67,68]. It has 
been shown that eight Rev monomers form a stable 
complex with the RRE [69]. The binding specificity of 
Rev for the RRE is determined by direct interactions 
between the Rev RNA-binding domain and the high- 
affinity binding site within the RRE. This complex is sta- 
bilized by a combination of less specific RNA-protein 
interactions and protein--protein interactions between Rev 
monomers [70]. Consistent with this model, Rev exists as 
an oligomer, most likely a tetramer, in solution [62,71]. 
The high-affinity binding site of HIV Rev is shown in 
Figure 4b. Two unconventional base-pair interactions 
between purines take place within the high-affinity 
binding site. The hydrogen-bonding arrangement of these 
unique base pairing interactions is shown in Figure 4c 
(the numbering of the nucleotide positions is based on 
the structure in Figure 4b). First, a G7-A,, base pair is 
located at the base of the mismatch region in the 
stem-loop structure. In addition, a Gs-G,, base pair is 
located within the high-affinity binding site on the loop 
side of the stem-loop structure. This Gs-GZ5 base pair 
can be replaced with an As-A,, base pair without perturb- 
ing Rev binding [72]. A single, non-base-paired U,, 
residue is located between these two mismatched base 
pairs. NMR analysis has revealed that the unique base 
Figure 4 
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Key structures involved in Rev binding to the RRE. (a) Amino acid 
sequence of the Rev arginine-rich motif (ARM). The numbering 
corresponds to the positions within HIV-l Rev. Residues in bold are 
involved in specific interactions with bases within the Rev high-affinity 
binding site. (b) Secondary RNA structure of the Rev high-affinity 
binding site. Non-Watson-Crick interactions between purine base 
pairs are illustrated with dotted lines. This sequence is derived from 
the region encompassing nucleotides 7808-7846 of HIV clone HXB2 
(GenBank accession number: K03455). (c) Hydrogen bonding 
stabilizes the two purine base pairs found in the Rev high-affinity 
binding site. (d) Schematic representation of the c-helical Rev ARM 
within the widened major groove of the Rev high-affinity binding site. 
The amino acids within double circles are involved in base-specific 
interactions. 
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pairing interactions within the Rev high-affinity binding 
site cause the major grove of the stem-loop to be 
widened. Widening of the major groove is essential for 
specific RNA-protein interactions within an RNA helix. 
This is because the major groove of a type A RNA helix is 
too narrow and deep to allow amino acid residues to reach 
into the RNA helix and ‘feel’ the specific nucleotides 
contained within. 
Insights into the details of the binding of Rev to the 
high-affinity binding site of the RRE have been revealed 
by several studies. Two groups have published NMR- 
derived structures of a peptide encompassing the Rev 
ARM bound to a small RNA containing a high-affinity 
binding site for Rev [73,74]. One study used sequences 
found in the RRE [73], while the other used an RNA 
aptamer which had been selected from a randomized pop- 
ulation and shown to interact efficiently with Rev in vitro. 
This aptamer contains the As-A,, base pair in place of the 
Gs-GZ6 base pair in the Rev high- affinity binding site, as 
described previously [72,74]. The studies resulted in 
nearly identical structures and they showed that the Rev 
peptide assumes an a-helical structure, as predicted by 
CD analysis. The phosphate backbone adjacent to the 
G,-Gz6 (or As-A,,) base pair adopts an unusual structure 
that allows the Rev peptide deep access within a widened 
major groove, as illustrated in Figure 4d. The helix pene- 
trates deep into the major groove of an RNA helix which 
has been widened by non-Watson-Crick base pairs. Asn40 
specifically interacts with the G,-A,, base pair and, along 
with Arg35, Arg39 and Arg44, makes base-specific interac- 
tions. Arg35 and Arg39 interact with U,,, G,,, and G,, on 
one side of the groove. Asn40 and Arg44 interact with U,, 
G,, G,, and A,, on the other side of the widened major 
groove. Other amino acids within the Rev ARM make a 
variety of contacts with the phosphate backbone. There- 
fore, a structure formed by two purine-purine base pairs 
within the RRE creates a distinct binding pocket, allowing 
specific recognition by the Rev ARM. 
The NMR structure of the Rev ARM binding to the Rev 
high-affinity binding site was validated by a study which 
identified supressor mutants of Rev that restored specific 
interactions with a mutant form of the Rev high-affinity 
binding site [75]. When A,, of the Rev high-affinity 
binding site was modified to G,,, Rev could no longer 
bind. This modification caused both purine base pairs in 
the Rev high-affinity binding site to be Gs-G,, interac- 
tions. Using an assay in Escherichia co/i in which 
RNA-protein interactions can be selected, a specific 
mutant of Rev, which interacted efficiently with the 
A,,+G mutant of the Rev high-affinity binding site, was 
identified. The modified versions of Rev interacted with 
the mutated binding site to allow RNA export in transfec- 
tion studies. This A,,+G mutant contained a modifica- 
tion of Asn40 to a glutamine. The observation that the 
change Asn40-+Glu in Rev could suppress the A2,+G 
mutation is consistent with the NMR structures which 
show key interactions between Asn40 and the G,-A,, 
base pair. 
Viral RNA export as a target for antiviral 
therapies 
It is now apparent that although viruses can exploit the 
typical cellular mRNA export pathway, they often use 
alternative export pathways. The challenge of developing 
a new antiviral therapy involves identifying an agent that 
negatively affects the pathogen but does not cause delete- 
rious side effects for the host or affect the endogenous use 
of, in this case, the export pathway. RNA export elements 
are promising potential targets for antiviral therapy 
because they are virus-specific RNA entities that are 
required for viral gene expression. There are currently 
several therapeutic strategies being developed to block 
HIV replication by inhibiting Rev function. These 
approaches can be separated into two groups: the first 
focuses on perturbing Rev function and the second disrupts 
or blocks the Rev high-affinity binding site. 
Several approaches to disrupting Rev function depend on 
gene therapy to allow the expression of inhibitory proteins 
and RNAs within a cell. For example, it has been shown 
that the expression of decoy RNAs, which will compete 
with the RRE for the Rev protein, can inhibit HIV repli- 
cation [76]. Dominant-negative versions of Rev can also 
be expressed within a cell, thereby blocking HIV replica- 
tion [77]. These dominant-negative mutants inactivate 
wild-type Rev monomers through the formation of non- 
functional oligomers [71]. Dominant-negative mutants of 
the eIF5A protein can also block HIV replication by inac- 
tivating Rev function [78]. Finally, intracellular immuniza- 
tion with single-chain anti-Rev antibodies cause Rev to be 
retained within the cytoplasm [79]. Unfortunately, these 
promising approaches cannot be realized or even tested 
until techniques for efficient gene delivery are developed. 
Other strategies focus on disrupting the Rev high-affinity 
binding site and the ability of Rev to interact with viral 
RNA. Antisense oligonucleotides which alter RNA folding 
and the formation of the Rev high-affinity binding site 
have shown some promise in cell culture [80&l]. But 
before the therapeutic use of antisense-based drugs can be 
realized, obstacles of oligonucleotide delivery and stability 
must be overcome. It has also been shown that certain 
aminoglycosides, like neomycin, can bind tightly to the 
Rev high-affinity binding site efficiently blocking 
Rev-RRE interactions [BZ]. These types of drug-based 
therapies which disrupt the site-specific RNA-protein 
interactions required for viral replication show more 
promise in the short-term future because the develop- 
ment of efficient gene delivery for gene therapy is a 
complex problem. 
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Drug-based therapies which disrupt the RNA-binding site 
for export proteins may also be useful for perturbing the 
function of viral RNA-export elements which bind cellular 
factors. Therapies that disrupt protein function in these 
cases will not work because the normal cellular function of 
these factors, presumably required for RNA export, will 
also be disrupted. But if a drug-based therapy to disrupt 
the binding site in viral RNA for cellular Rev-like proteins 
can be developed, this :approach could be used to inhibit 
the replication of most, if not all, viruses which replicate in 
the nucleus. Therefore, the future potential of therapies 
which disrupt the nuclear export of unconventional viral 
RNAs holds great promise in the ongoing battle between 
man and many virally induced diseases. 
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